Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1,001 - 10,000 - Monthly Reach
Unique listeners across all episodes (30 days)
5,001 - 25,000 - Active Followers
Loyal subscribers who consistently listen
5,001 - 15,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
Phenoconversion in Pure Autonomic Failure
May 4, 2026
24m 01s
Brain Biomarkers and a Multidomain Lifestyle Intervention
Apr 20, 2026
22m 03s
Epstein-Barr Virus Antibodies and Multiple Sclerosis
Mar 9, 2026
14m 58s
Comparative Effectiveness of Brivaracetam, Cenobamate,Lacosamide, and Perampanel in Focal Epilepsy
Feb 9, 2026
16m 59s
US Burden of Disorders Affecting the Nervous System
Nov 24, 2025
23m 33s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 5/4/26 |  Phenoconversion in Pure Autonomic Failure✨ | autonomic failureneurology+4 | Alessandra Fanciulli, MD, PhDEduardo de Pablo-Fernández, MD, PhD+2 | Phenoconversion in Pure Autonomic Failure: A Systematic Review and Meta-AnalysisPhenoconversion in Pure Autonomic Failure+1 | — | phenoconversionpure autonomic failure+5 | — | 24m 01s | |
| 4/20/26 |  Brain Biomarkers and a Multidomain Lifestyle Intervention✨ | brain biomarkerslifestyle intervention+3 | Susan M. Landau, PhD | Brain Imaging Biomarkers and Cognitive Outcomes in a Multidomain Lifestyle Intervention | — | brain biomarkerscognitive outcomes+3 | — | 22m 03s | |
| 3/9/26 |  Epstein-Barr Virus Antibodies and Multiple Sclerosis✨ | Epstein-Barr VirusMultiple Sclerosis+3 | Hannes Vietzen | Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases | — | Epstein-Barr VirusMultiple Sclerosis+3 | — | 14m 58s | |
| 2/9/26 |  Comparative Effectiveness of Brivaracetam, Cenobamate,Lacosamide, and Perampanel in Focal Epilepsy✨ | focal epilepsycomparative effectiveness+3 | Emanuele Cerulli Irelli, MD, PhD | Comparative Effectiveness of Brivaracetam, Cenobamate,Lacosamide, and Perampanel in Focal Epilepsy | — | BrivaracetamCenobamate+6 | — | 16m 59s | |
| 11/24/25 |  US Burden of Disorders Affecting the Nervous System✨ | nervous system disordersglobal burden of disease+3 | John P. Ney, MD, MPH | Global Burden of Disease 2021 StudyUS Burden of Disorders Affecting the Nervous System | — | nervous systemdisorders+3 | — | 23m 33s | |
| 10/6/25 |  Hemorrhage and Risk Factors in Unruptured Brain AVM✨ | brain arteriovenous malformationshemorrhage risk+3 | Helen Kim, PhD | Risk of Future Hemorrhage From Unruptured Brain Arteriovenous Malformations: The Multicenter Arteriovenous Malformation Research Study (MARS) | — | brain AVMhemorrhage+3 | — | 16m 38s | |
| 8/18/25 |  Intravenous Argatroban or Eptifibatide and Mechanical Thrombectomy✨ | mechanical thrombectomyclinical trial+3 | Colin P. Derdeyn, MD | Intravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy: A Subgroup Analysis of the MOST Randomized Clinical TrialIntravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy | — | argatrobaneptifibatide+5 | — | 19m 09s | |
| 7/14/25 |  GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension✨ | idiopathic intracranial hypertensionGLP-1 receptor agonists+3 | Dennis J. Rivet II, MD | GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension | — | GLP-1 receptor agonistsidiopathic intracranial hypertension+3 | — | 22m 03s | |
| 6/2/25 |  Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome✨ | Multiple SclerosisRadiologically Isolated Syndrome+3 | Manuel Comabella, MD | Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome | — | Multiple SclerosisRadiologically Isolated Syndrome+3 | — | 14m 19s | |
| 5/5/25 |  Fremanezumab for the Treatment of Migraine and Major Depressive Disorder✨ | migrainemajor depressive disorder+3 | Richard B. Lipton, MD | Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder | — | fremanezumabmigraine treatment+3 | — | 21m 13s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 3/31/25 |  Optimal Delay Time to Initiate Anticoagulation After AF-Associated Ischemic Stroke | Interview with Steven J. Warach, MD, PhD, author of Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation | — | ||||||
| 3/3/25 |  Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage | Interview with David J. Seiffge, MD, author of Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage. Hosted by Cynthia E. Armand, MD. Related Content: Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage | — | ||||||
| 1/6/25 |  Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine | Interview with Wei-Hsuan Lo-Ciganic, PhD, author of Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine. Hosted by Cynthia E. Armand, MD. Related Content: Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine | — | ||||||
| 12/2/24 |  β-Blocker Use and Delayed Onset and Progression of Huntington Disease | Interview with Jordan L. Schultz, PharmD, author of β-Blocker Use and Delayed Onset and Progression of Huntington Disease. Hosted by Cynthia E. Armand, MD. Related Content: β-Blocker Use and Delayed Onset and Progression of Huntington Disease | — | ||||||
| 11/1/24 |  Alzheimer Disease as a Clinical-Biological Construct | Interview with Giovanni B. Frisoni, MD, author of Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation. Hosted by Cynthia E. Armand, MD. Related Content: Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation | — | ||||||
| 9/23/24 |  Perceived CTE in Former Professional Football Players | Interview with Rachel Grashow, PhD, MS, and Aaron L. Baggish, MD, authors of Perceived Chronic Traumatic Encephalopathy and Suicidality in Former Professional Football Players. Hosted by Cynthia E. Armand, MD. In the US, you can call, text, or chat 988, the Suicide and Crisis Lifeline. Related Content: Perceived Chronic Traumatic Encephalopathy and Suicidality in Former Professional Football Players | — | ||||||
| 8/19/24 |  Localized Nicardipine Release Implants for Prevention of Vasospasm | Interview with Peter Vajkoczy, MD, author of Localized Nicardipine Release Implants for Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Localized Nicardipine Release Implants for Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage | — | ||||||
| 7/8/24 |  Direct-Acting OACs and Antiseizure Medications for AF and Epilepsy and Risk of Thromboembolic Events | Interview with Allison W. Willis, MD, MS, author of Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events. Hosted by Cynthia E. Armand, MD. Related Content: Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events | — | ||||||
| 5/28/24 |  Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation | Interview with Urs Fischer, MD, MSc, author of Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation | — | ||||||
| 4/29/24 |  Association of New-Onset Seizures With SARS-CoV-2 Vaccines | Interview with Churl-Su Kwon, MD, MPH, author of Association of New-Onset Seizures With SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Hosted by Cynthia E. Armand, MD. Related Content: Association of New-Onset Seizures With SARS-CoV-2 Vaccines | — | ||||||
| 3/25/24 |  High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS | Interview with Anne Kerbrat, MD, PhD, author of High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS. Hosted by Cynthia E. Armand, MD. Related Content: High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS | — | ||||||
| 2/26/24 |  Posttraumatic Epilepsy and Dementia Risk | Interview with Andrea L. C. Schneider, MD, PhD, author of Posttraumatic Epilepsy and Dementia Risk. Hosted by Cynthia E. Armand, MD. Related Content: Posttraumatic Epilepsy and Dementia Risk | — | ||||||
| 2/5/24 |  Risk of Stroke and Myocardial Infarction Among Initiators of Triptans | Interview with Jesper Hallas, MD, DMSc, author of Risk of Stroke and Myocardial Infarction Among Initiators of Triptans. Hosted by Cynthia E. Armand, MD. Related Content: Risk of Stroke and Myocardial Infarction Among Initiators of Triptans | — | ||||||
| 12/26/23 |  Risk Factors for Young-Onset Dementia in the UK Biobank | Interview with Stevie Hendriks, PhD, author of Risk Factors for Young-Onset Dementia in the UK Biobank. Hosted by Cynthia E. Armand, MD. Related Content: Risk Factors for Young-Onset Dementia in the UK Biobank | — | ||||||
| 11/27/23 |  Endovascular Therapy Outcomes by ASPECTS and Infarct Core Volume in Patients With Large Infarct | Interview with Zhongrong Miao, MD, author of Alberta Stroke Program Early Computed Tomography Score, Infarct Core Volume, and Endovascular Therapy Outcomes in Patients With Large Infarct: A Secondary Analysis of the ANGEL-ASPECT Trial. Hosted by Cynthia E. Armand, MD. Read Transcript Related Content: Alberta Stroke Program Early Computed Tomography Score, Infarct Core Volume, and Endovascular Therapy Outcomes in Patients With Large Infarct | — | ||||||
Showing 25 of 126
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
8 placements across 8 markets.
Chart Positions
8 placements across 8 markets.